William David Kent, MD | |
2257 Mcdowell Rd, Saint Thomas, PA 17252-9715 | |
(717) 658-1519 | |
Not Available |
Full Name | William David Kent |
---|---|
Gender | Male |
Speciality | Family Medicine - Hospice And Palliative Medicine |
Location | 2257 Mcdowell Rd, Saint Thomas, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578563318 | NPI | - | NPPES |
4603564 | Other | PA | AETNA NON-HMO |
831281 | Other | PA | AETNA HMO |
G920-0038/KDM4CU | Other | PA | CAREFIRST |
MD019478E | Other | PA | PA LICENSE |
25-1716306 | Other | PA | INTERGROUP |
87050 | Other | PA | HIGHMARK BLUE SHIELD |
1007307260034 | Other | PA | MEDICAID GROUP # |
122763 | Other | PA | UNISON |
1329775 | Other | FIRST HEALTH | |
25-1716306 | Other | PA | MULTIPLAN/PHCS |
0006163620003 | Medicaid | PA | |
424178 | Other | PA | HEALTH AMERICA |
120420408 | Other | PA | DEPT OF LABOR |
25-1716306 | Other | PA | DEVON |
867633 | Other | PA | MEDICARE GROUP # |
080142010 | Other | PA | RAILROAD MEDICARE |
25-1716306 | Other | PA | HEALTHNET/TRICARE |
25-1716306 | Other | PA | GREATWEST |
P005049 | Other | PA | GATEWAY |
25-1716306 | Other | PA | INFORMED |
25-1716306 | Other | PA | SOUTH CENTRAL PREFERRED |
292258 | Other | PA | MAMSI |
50001095 | Other | PA | CAPITAL BLUECROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD019478E (Pennsylvania) | Secondary |
207QH0002X | Family Medicine - Hospice And Palliative Medicine | MD019478E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
William David Kent, MD 2257 Mcdowell Rd, Saint Thomas, PA 17252-9715 Ph: () - | William David Kent, MD 2257 Mcdowell Rd, Saint Thomas, PA 17252-9715 Ph: (717) 658-1519 |
News Archive
The Huffington Post has several commentaries about the 30th anniversary of AIDS and other issues surrounding the epidemic.
The interventional cardiology team at the Montreal Heart Institute (MHI) used the world's first drug eluting bioresorbable vascular scaffold to successfully treat a woman suffering from coronary artery disease. This landmark procedure was performed by Dr. Jean-Fran-ois Tanguay, interventional cardiologist and coordinator of the Coronary Unit, as part of the ABSORB EXTEND clinical trial.
An earplug with a built-in computer that allows speech to pass but shuts out unwanted and hazardous noise will make life easier in noisy environments.
A phase II, randomized clinical trial found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should begin 60 to 90 days after the event.
ICF International (NASDAQ:ICFI) was awarded a new, five-year contract valued at more than $7 million with the U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA).
› Verified 3 days ago